Zurich Insurance Sale of German Life Legacy Assets Won't Close As Planned
By David Sachs
Zurich Insurance Group said Tuesday that Viridium Group won't buy its legacy life insurance policy business in Germany as planned.
The Swiss insurance company had planned to sell Zurich Life Legacy to the German insurance platform since 2022. The transaction was meant to include the transfer of $20 billion in net reserves, mostly related to annuity and endowment products.
"Zurich is committed to finding a solution for this portfolio and will explore options in due course," Zurich said.
The company's financial targets nor capital management plans will be affected, Zurich said.
Write to David Sachs at david.sachs@wsj.com
Corrections & Amplifications
This article was corrected at 0941 GMT to clarify that Zurich Insurance Group said it has been informed that Viridium Group won't buy its life legacy business in Germany as planned. An earlier article incorrectly said Zurich had said the sale had been canceled.
(END) Dow Jones Newswires
January 30, 2024 02:36 ET (07:36 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks